Merck & Co., Inc. — Director's Dealing 2018

Feb 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-02-09

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-09	Common Stock	M	8572.0000	$0.0000	Acquired	45779.8410	Direct
2018-02-09	Common Stock	F	2974.0000	$54.7300	Disposed	42805.8410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-09	Restricted Stock Unit	$	M	8572.0000	Disposed	2018-02-09	Common Stock (8572.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock - 401(k) Plan	1038.0736	Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through January 8, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.